The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.
[url="]Vertex Pharmaceuticals Incorporated[/url] (Nasdaq: VRTX) today announced management participation in three upcoming investor conferences.
Stuart Arbuc
AM Best has assigned a Financial Strength Rating of A (Excellent) and a Long-Term Issuer Credit Rating of “a” (Excellent) to Torreyana Insurance Company, Inc. (TIC) (Burlington,
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...
Vertex Pharmaceuticals Incorporated VRTX reported mixed results for its fourth quarter on Monday.
The company posted quarterly adjusted earnings of $3.48 per s...
Vertex Pharmaceuticals Incorporated VRTX will release its fourth-quarter financial results, after the closing bell, on Monday, Feb. 10, 2025.
Analysts expect t...
A real-time update on the Q4 earnings season is included in today's Research Daily, in addition to featuring updated analyst reports on Meta Platforms (META), Mastercard (MA), Adobe (ADBE) and others.
U.S. stocks were higher, with the Nasdaq Composite gaining more than 1% on Friday.
Shares of Charter Communications, Inc. CHTR rose during Friday's session aft...
We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against the ...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...
Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
[url="]Vertex Pharmaceuticals Incorporated[/url] (Nasdaq: VRTX) will report its fourth quarter and full year 2024 financial results on Monday, February 10, 202